“Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s251, https://doi.org/10.25251/skin.7.supp.251.